Investors
CORRECTION: MAR removed. Freemelt strengthens the management team and appoints Karin Stenback as CTO
Karin Stenback has been appointed as CTO (Chief Technology Officer) and will be part of Freemelt’s executive management team. Karin currently serves as R&D Director at Breas Medical AB and has extensive experience in senior leadership positions within global industrial companies, particularly in the medical technology and automotive industries.
“With over 20 years of experience in global industrial companies, I’m looking forward to joining Freemelt and being a part of the next phase in accelerating the industrialization of the company and its products. My experience in leading teams and projects across multiple markets aligns well with the current position of Freemelt,” says Karin Stenback.
“Karin brings international experience in product development, commercialization, and leadership within highly regulated industries, similar to the industries Freemelt serves. This is a strategically important recruitment further strengthening our team as we advance to the next level of industrialization,” says Daniel Gidlund CEO Freemelt.
Karin will assume the role no later than June 17, 2025.